Anaphylaxis knowledge gaps and future research priorities: A consensus report.

Allergy anaphylaxis basic science emergency department feasibility impact population science research translational science

Journal

The Journal of allergy and clinical immunology
ISSN: 1097-6825
Titre abrégé: J Allergy Clin Immunol
Pays: United States
ID NLM: 1275002

Informations de publication

Date de publication:
03 2022
Historique:
received: 14 06 2021
revised: 23 07 2021
accepted: 29 07 2021
pubmed: 15 8 2021
medline: 26 4 2022
entrez: 14 8 2021
Statut: ppublish

Résumé

Despite a better understanding of the epidemiology, pathogenesis, and management of patients with anaphylaxis, there remain knowledge gaps. Enumerating and prioritizing these gaps would allow limited scientific resources to be directed more effectively. We sought to systematically describe and appraise anaphylaxis knowledge gaps and future research priorities based on their potential impact and feasibility. We convened a 25-member multidisciplinary panel of anaphylaxis experts. Panelists formulated knowledge gaps/research priority statements in an anonymous electronic survey. Four anaphylaxis themed writing groups were formed to refine statements: (1) Population Science, (2) Basic and Translational Sciences, (3) Emergency Department Care/Acute Management, and (4) Long-Term Management Strategies and Prevention. Revised statements were incorporated into an anonymous electronic survey, and panelists were asked to rate the impact and feasibility of addressing statements on a continuous 0 to 100 scale. The panel generated 98 statements across the 4 anaphylaxis themes: Population Science (29), Basic and Translational Sciences (27), Emergency Department Care/Acute Management (24), and Long-Term Management Strategies and Prevention (18). Median scores for impact and feasibility ranged from 50.0 to 95.0 and from 40.0 to 90.0, respectively. Key statements based on median rating for impact/feasibility included the need to refine anaphylaxis diagnostic criteria, identify reliable diagnostic, predictive, and prognostic anaphylaxis bioassays, develop clinical prediction models to standardize postanaphylaxis observation periods and hospitalization criteria, and determine immunotherapy best practices. We identified and systematically appraised anaphylaxis knowledge gaps and future research priorities. This study reinforces the need to harmonize scientific pursuits to optimize the outcomes of patients with and at risk of anaphylaxis.

Sections du résumé

BACKGROUND
Despite a better understanding of the epidemiology, pathogenesis, and management of patients with anaphylaxis, there remain knowledge gaps. Enumerating and prioritizing these gaps would allow limited scientific resources to be directed more effectively.
OBJECTIVE
We sought to systematically describe and appraise anaphylaxis knowledge gaps and future research priorities based on their potential impact and feasibility.
METHODS
We convened a 25-member multidisciplinary panel of anaphylaxis experts. Panelists formulated knowledge gaps/research priority statements in an anonymous electronic survey. Four anaphylaxis themed writing groups were formed to refine statements: (1) Population Science, (2) Basic and Translational Sciences, (3) Emergency Department Care/Acute Management, and (4) Long-Term Management Strategies and Prevention. Revised statements were incorporated into an anonymous electronic survey, and panelists were asked to rate the impact and feasibility of addressing statements on a continuous 0 to 100 scale.
RESULTS
The panel generated 98 statements across the 4 anaphylaxis themes: Population Science (29), Basic and Translational Sciences (27), Emergency Department Care/Acute Management (24), and Long-Term Management Strategies and Prevention (18). Median scores for impact and feasibility ranged from 50.0 to 95.0 and from 40.0 to 90.0, respectively. Key statements based on median rating for impact/feasibility included the need to refine anaphylaxis diagnostic criteria, identify reliable diagnostic, predictive, and prognostic anaphylaxis bioassays, develop clinical prediction models to standardize postanaphylaxis observation periods and hospitalization criteria, and determine immunotherapy best practices.
CONCLUSIONS
We identified and systematically appraised anaphylaxis knowledge gaps and future research priorities. This study reinforces the need to harmonize scientific pursuits to optimize the outcomes of patients with and at risk of anaphylaxis.

Identifiants

pubmed: 34390722
pii: S0091-6749(21)01209-4
doi: 10.1016/j.jaci.2021.07.035
pmc: PMC8837706
mid: NIHMS1732748
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

999-1009

Subventions

Organisme : AHRQ HHS
ID : K08 HS026503
Pays : United States
Organisme : NCATS NIH HHS
ID : KL2 TR001426
Pays : United States
Organisme : Medical Research Council
ID : MR/K010468/1
Pays : United Kingdom
Organisme : NCATS NIH HHS
ID : UL1 TR001425
Pays : United States

Informations de copyright

Copyright © 2021 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Références

J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
J Allergy Clin Immunol Pract. 2020 Jan;8(1):125-131
pubmed: 31382040
J Allergy Clin Immunol Pract. 2020 Apr;8(4):1169-1176
pubmed: 31786255
J Allergy Clin Immunol. 2017 Apr;139(4):1099-1110
pubmed: 28257972
N Engl J Med. 2019 Dec 12;381(24):2338-2351
pubmed: 31826341
J Allergy Clin Immunol Pract. 2019 Apr;7(4):1125-1133.e1
pubmed: 30737190
J Allergy Clin Immunol Pract. 2021 May;9(5):1826-1838.e8
pubmed: 33684637
Ann Allergy Asthma Immunol. 2021 Feb;126(2):168-174.e3
pubmed: 32911059
Resuscitation. 2021 Apr 23;163:86-96
pubmed: 33895231
J Allergy Clin Immunol. 2009 Oct;124(4):786-92.e4
pubmed: 19767073
J Allergy Clin Immunol. 2021 Jul;148(1):86-88
pubmed: 33965430
J Allergy Clin Immunol. 2021 Feb;147(2):622-632
pubmed: 32717252
Nat Med. 2019 Mar;25(3):448-453
pubmed: 30643289
Acad Emerg Med. 2016 May;23(5):623-7
pubmed: 26833535
Lancet. 2019 Jun 1;393(10187):2222-2232
pubmed: 31030987
J Allergy Clin Immunol Pract. 2017 Sep - Oct;5(5):1169-1178
pubmed: 28888247
J Clin Invest. 2020 Sep 1;130(9):4759-4770
pubmed: 32484802
Front Immunol. 2018 Jul 17;9:1584
pubmed: 30065721
Immunol Allergy Clin North Am. 2012 Feb;32(1):165-95
pubmed: 22244239
Ann Allergy Asthma Immunol. 2020 Aug;125(2):124-125
pubmed: 32497713
Allergy. 2014 Aug;69(8):1026-45
pubmed: 24909803
Clin Exp Allergy. 2018 Dec;48(12):1584-1593
pubmed: 30288817
J Allergy Clin Immunol. 2021 Feb;147(2):633-642
pubmed: 32707226
Lancet Respir Med. 2015 May;3(5):350-1
pubmed: 25969360
J Allergy Clin Immunol. 2021 Jul;148(1):173-181
pubmed: 33476673
J Allergy Clin Immunol Pract. 2019 Apr;7(4):1148-1156.e5
pubmed: 30737191
N Engl J Med. 2004 Aug 12;351(7):668-74
pubmed: 15306668
J Allergy Clin Immunol Pract. 2021 Jun;9(6):2235-2242
pubmed: 33744473
J Allergy Clin Immunol. 2017 Aug;140(2):321-333
pubmed: 28780940
J Allergy Clin Immunol. 2018 Jul;142(1):159-170.e2
pubmed: 29518427
Sci Rep. 2020 Jan 20;10(1):659
pubmed: 31959857
J Allergy Clin Immunol Pract. 2021 Jan;9(1):527-530.e1
pubmed: 32889224
J Allergy Clin Immunol. 2013 Nov;132(5):1141-1149.e5
pubmed: 23915715
J Allergy Clin Immunol Pract. 2020 Feb;8(2):565-572
pubmed: 31626991
Ann Allergy Asthma Immunol. 2020 May;124(5):473-478
pubmed: 31923546
J Allergy Clin Immunol Pract. 2021 Jan;9(1):311-320.e2
pubmed: 33217612
Allergy. 2017 Jul;72(7):1006-1021
pubmed: 28122115
Allergy. 2020 Sep;75(9):2206-2218
pubmed: 32578235
Kolner Z Soz Sozpsychol. 2017;69(Suppl 2):107-131
pubmed: 28989188
J Allergy Clin Immunol. 2014 Feb;133(2):461-7
pubmed: 24144575
J Allergy Clin Immunol. 2021 Jul;148(1):83-85
pubmed: 33901514
J Allergy Clin Immunol Pract. 2016 May-Jun;4(3):497-504
pubmed: 26895621
J Allergy Clin Immunol. 2016 Jun;137(6):1674-1680
pubmed: 27130857
N Engl J Med. 2008 Jan 3;358(1):28-35
pubmed: 18172172
Curr Opin Allergy Clin Immunol. 2016 Oct;16(5):441-50
pubmed: 27490124
J Allergy Clin Immunol Pract. 2016 Nov - Dec;4(6):1220-1226
pubmed: 27406968
J Allergy Clin Immunol. 2021 Feb;147(2):653-662.e9
pubmed: 32585173
J Med Internet Res. 2001 Apr-Jun;3(2):E20
pubmed: 11720962
Curr Allergy Asthma Rep. 2018 Nov 15;18(12):77
pubmed: 30430289
J Allergy Clin Immunol. 2020 Apr;145(4):1082-1123
pubmed: 32001253
World Allergy Organ J. 2019 Oct 31;12(10):100066
pubmed: 31719946
J Allergy Clin Immunol. 2011 Mar;127(3):661-7
pubmed: 21377035
Front Immunol. 2016 Jan 06;6:620
pubmed: 26779180
J Allergy Clin Immunol. 2006 Feb;117(2):391-7
pubmed: 16461139
Ethn Dis. 2020 Apr 2;30(Suppl 1):129-134
pubmed: 32269453
J Allergy Clin Immunol Pract. 2020 Feb;8(2):767-768.e2
pubmed: 31466851
J Allergy Clin Immunol Pract. 2020 Jul - Aug;8(7):2310-2321.e4
pubmed: 32417446
J Allergy Clin Immunol Pract. 2014 Jul-Aug;2(4):414-20
pubmed: 25017529
J Allergy Clin Immunol Pract. 2020 Apr;8(4):1400-1402.e2
pubmed: 31605763
J Allergy Clin Immunol. 2021 Apr;147(4):1123-1131
pubmed: 33832694
JAMA Netw Open. 2019 Oct 2;2(10):e1913951
pubmed: 31642933
World Allergy Organ J. 2020 Oct 30;13(10):100472
pubmed: 33204386
J Allergy Clin Immunol. 2015 Apr;135(4):956-963.e1
pubmed: 25468198
J Allergy Clin Immunol. 2012 Mar;129(3):748-52
pubmed: 22051698
N Engl J Med. 2012 Jul 19;367(3):233-43
pubmed: 22808958
Science. 2019 Aug 30;365(6456):
pubmed: 31371561
J Allergy Clin Immunol. 2020 Nov;146(5):1089-1096
pubmed: 32853640
Ann Allergy Asthma Immunol. 2019 Apr;122(4):373-380.e1
pubmed: 30703439

Auteurs

Timothy E Dribin (TE)

Division of Emergency Medicine, Cincinnati Children's Hospital Medical Center, and the Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio. Electronic address: Timothy.Dribin@cchmc.org.

David Schnadower (D)

Division of Emergency Medicine, Cincinnati Children's Hospital Medical Center, and the Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio.

Julie Wang (J)

Division of Allergy and Immunology, Icahn School of Medicine at Mount Sinai, New York, NY.

Carlos A Camargo (CA)

Department of Emergency Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Mass.

Kenneth A Michelson (KA)

Division of Emergency Medicine, Boston Children's Hospital, and the Department of Pediatrics, Harvard Medical School, Boston, Mass.

Marcus Shaker (M)

Dartmouth Geisel School of Medicine, and Dartmouth-Hitchcock Medical Center, Hanover and Lebanon, NH.

Susan A Rudders (SA)

Division of Immunology, Boston Children's Hospital, and the Department of Pediatrics, Harvard Medical School, Boston, Mass.

David Vyles (D)

Section of Pediatric Emergency Medicine, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, Wis.

David B K Golden (DBK)

Division of Allergy and Clinical Immunology, Johns Hopkins University School of Medicine, Baltimore, Md.

Jonathan M Spergel (JM)

Division of Allergy and Immunology, Children's Hospital of Philadelphia, Perelman School of Medicine at University of Pennsylvania, Philadelphia, Pa.

Ronna L Campbell (RL)

Department of Emergency Medicine, Mayo Clinic, Rochester, NY.

Mark I Neuman (MI)

Division of Emergency Medicine, Boston Children's Hospital, and the Department of Pediatrics, Harvard Medical School, Boston, Mass.

Peter S Capucilli (PS)

Rochester Regional Health, Rochester, NY.

Michael Pistiner (M)

Department of Pediatrics, Massachusetts General Hospital for Children, Harvard Medical School, Boston, Mass.

Mariana Castells (M)

Division of Allergy and Clinical Immunology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass.

Juhee Lee (J)

Division of Allergy and Immunology, Children's Hospital of Philadelphia, Perelman School of Medicine at University of Pennsylvania, Philadelphia, Pa.

David C Brousseau (DC)

Section of Pediatric Emergency Medicine, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, Wis.

Lynda C Schneider (LC)

Division of Immunology, Boston Children's Hospital, and the Department of Pediatrics, Harvard Medical School, Boston, Mass.

Amal H Assa'ad (AH)

Division of Allergy and Immunology, Cincinnati Children's Hospital Medical Center, and the Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio.

Kimberly A Risma (KA)

Division of Allergy and Immunology, Cincinnati Children's Hospital Medical Center, and the Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio.

Rakesh D Mistry (RD)

Section of Emergency Medicine, Department of Pediatrics, Children's Hospital Colorado, Aurora, Colo.

Dianne E Campbell (DE)

Sydney Medical School, University of Sydney, Sydney, Australia; Department of Allergy and Immunology, Children's Hospital at Westmead, Sydney, Australia.

Margitta Worm (M)

Division of Allergy and Immunology, Department of Dermatology and Allergology, Charite-Universitätsmedizin Berlin, Berlin, Germany.

Paul J Turner (PJ)

National Heart & Lung Institute, Imperial College London, London, United Kingdom.

John K Witry (JK)

Division of Emergency Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.

Yin Zhang (Y)

Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio; Division of Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.

Brad Sobolewski (B)

Division of Emergency Medicine, Cincinnati Children's Hospital Medical Center, and the Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio.

Hugh A Sampson (HA)

Division of Allergy and Immunology, Icahn School of Medicine at Mount Sinai, New York, NY.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH